# EDGAR Filing Document

**Accession Number:** 0001835033
**File Stem:** 0001835033-26-000005
**Filing Date:** 2026-2
**Character Count:** 7061
**Document Hash:** dfe4174eda9684ce37453aa9e785918b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001835033-26-000005.hdr.sgml**: 20260219

**ACCESSION NUMBER**: 0001835033-26-000005

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260218

**FILED AS OF DATE**: 20260219

**DATE AS OF CHANGE**: 20260219

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Orr Patrick J
- **CENTRAL INDEX KEY:** 0001835033

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-12015
- **FILM NUMBER:** 26656398

**MAIL ADDRESS:**
- **STREET 1:** 3220 TILLMAN DRIVE
- **STREET 2:** SUITE 300
- **CITY:** BENSALEM
- **STATE:** PA
- **ZIP:** 19020
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HEALTHCARE SERVICES GROUP INC
- **CENTRAL INDEX KEY:** 0000731012
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-NURSING & PERSONAL CARE FACILITIES [8050]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 232018365
- **STATE OF INCORPORATION:** PA
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3220 TILLMAN DRIVE
- **STREET 2:** SUITE 300
- **CITY:** BENSALEM
- **STATE:** PA
- **ZIP:** 19020
- **BUSINESS PHONE:** 2159381661

**MAIL ADDRESS:**
- **STREET 1:** 3220 TILLMAN DRIVE
- **STREET 2:** SUITE 300
- **CITY:** BENSALEM
- **STATE:** PA
- **ZIP:** 19020

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Orr Patrick J<br><sub>(Last) (First) (Middle)</sub><br>3220 TILLMAN DRIVE<br>SUITE 300<br><sub>(Street)</sub><br>BENSALEM, PA 19020<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-02-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_EVP & Chief Revenue Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>HEALTHCARE SERVICES GROUP INC [ HCSG ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-02-18 |  | M |  | 21075 | A | $18.10 | 65690 | D |  |
| Common Stock | 2026-02-18 |  | M |  | 7016 | A | $13.72 | 72706 | D |  |
| Common Stock | 2026-02-18 |  | M |  | 12216 | A | $10.36 | 84922 | D |  |
| Common Stock | 2026-02-18 |  | M |  | 5193 | A | $11.76 | 90115 | D |  |
| Common Stock | 2026-02-18 |  | S |  | 45500 | D | $20.54 | 44615 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option (right to buy) | $18.10 | 2026-02-18 |  | M |  |  | 21075 | <sup>(1)</sup> | 2032-01-04 | Common Stock | 21075 | $0 | 5268 | D |  |
| Stock Option (right to buy) | $13.72 | 2026-02-18 |  | M |  |  | 7016 | <sup>(2)</sup> | 2033-02-24 | Common Stock | 7016 | $0 | 10524 | D |  |
| Stock Option (right to buy) | $10.36 | 2026-02-18 |  | M |  |  | 12216 | <sup>(3)</sup> | 2034-01-03 | Common Stock | 12216 | $0 | 18322 | D |  |
| Stock Option (right to buy) | $11.76 | 2026-02-18 |  | M |  |  | 5193 | <sup>(4)</sup> | 2035-01-03 | Common Stock | 5193 | $0 | 20772 | D |  |

---

### Footnotes:

(1) These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2022 grant date.

(2) These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the February 24, 2023 grant date.

(3) These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2024 grant date.

(4) These Options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2025 grant date.

**Signature:** Michael Harrity, by Power of Attorney  
**Date:** 2026-02-19

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**